| Market Cap | ₹2,703Cr |
| ROE | 10.81% |
| P/E Ratio(TTM) | 36.95 |
| EPS(TTM) | 7.81 |
| P/B Ratio | 3.93 |
| Dividend Yield | 0.13% |
| Industry P/E | 35.00 |
| Book Value | 73.39 |
| Debt to Equity | 0.49 |
| Face Value | 1 |
| Parent Organisation | Sms Pharmaceuticals |
| Managing Director | Shri. Ramesh Potluri |
| NSE Symbol | SMSPHARMA |
| FUND NAME | AUM(%) |
|---|---|
| Quant Small Cap Fund Direct Plan Growth | 0.16% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 76.59 | ||
| Neuland Laboratories | NA (0.00%) | 117.77 | ||
| Jubilant Pharmova | NA (0.00%) | 39.02 | ||
| Acutaas Chemicals | NA (0.00%) | 61.88 |